These payer mechanisms reflect limited public reimbursement coverage for obesity pharmacotherapy under the National Health Insurance system
Choose Sermorelin If Your Goals Are Building lean muscle or improving body composition Losing stubborn body fat, especially around the midsection Improving athletic performance and recovery Increasing energy and reducing fatigue Supporting bone density and immune function A natural approach to restoring growth hormone levels Choose PT-141 If Your Goals Are Enhancing sexual desire and libido Improving arousal and performance (men or women) Addressing erectile dysfunction from a brain-based approach Restoring desire that blood-flow treatments haven't fully addressed Enhancing intimacy as a couple Choose GHK-Cu Cream If Your Goals Are Reducing fine lines and wrinkles Improving skin firmness and elasticity Brightening dull, uneven skin Repairing sun damage A no-injection, topical approach to anti-aging Not sure
Dose control protocols Avoid automatic titration
Tirzepatide, a dual GLP-1 and GIP receptor agonist, has demonstrated superior efficacy for weight reduction and improved metabolic health compared with single GLP-1 agonists
Unlike endogenous -MSH, which degrades within seconds via enzymatic cleavage, MT-1's modified structure resists degradation by serum proteases, allowing sustained melanocortin receptor activation across multiple tissue types
Low levels of digestive enzymes, such as DAO, are known to break down histamine within the body